GALT Latest Press Releases

-- October 6, 2026 --

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 Globe Newswire 8:00 AM

-- September 10, 2026 --

Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 14, 2026 --

Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- August 4, 2026 --

Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet Globe Newswire 8:00 AM

-- June 23, 2026 --

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension Globe Newswire 8:00 AM

-- May 27, 2026 --

Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin's Potential to Modify Disease Progression in Advanced MASH Cirrhosis Globe Newswire 8:00 AM

-- May 15, 2026 --

Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software